BACKGROUND Rheumatoid arthritis (RA) is an autoimmune disease, the most common
type of inflammatory arthritis that affects more than 1.3 million Americans. Of these, about …

The 2008 American College of Rheumatology recommendations for the use of nonbiologic and
biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets …

The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …

Guidelines and recommendations developed and/or endorsed by the American College of
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice …

History of Present Illness: A 50-year-old woman who works as an administrative assistant
has had persistent hand pain and stiffness for 3 months. Two weeks ago, her right wrist …

Rheumatoid arthritis (RA) is a chronic, progressive, autoimmune inflammatory disease of the
joints, which can result in permanent cartilage and bone damage. Although the exact cause …

The 2015 Annual meeting of the American College of Rheumatology (ACR) and Association
of Rheumatology Health Professionals (ACR/ARHP), held in San Francisco, California …

The development of targeted therapy with a biologic agent for rheumatoid arthritis (RA) has
revolutionized treatment of this chronic disease and provided clinicians with a diverse menu …

The 2015 Annual meeting of the American College of Rheumatology (ACR) and Association
of Rheumatology Health Professionals (ACR/ARHP), held in San Francisco, California …

Rheumatoid arthritis requires early intervention to prevent long-term complications and
morbidity. The exact trigger is unknown, but symmetrical synovitis in the small joints of the …